In a powerful story of resilience and medical innovation, Hollywood actor Sam Neill has announced he is now cancer-free after undergoing a cutting-edge treatment for his stage-three blood cancer. The 78-year-oldJurassic Parkstar revealed that after chemotherapy stopped working, a clinical trial using CAR T-cell therapy helped eliminate cancer from his body - offering new hope for patients worldwide.
Neill was diagnosed with angioimmunoblastic T-cell lymphoma, a rare and aggressive form of blood cancer. He first shared his diagnosis in his 2023 memoir,Did I Ever Tell You This?, explaining that while chemotherapy initially kept the disease under control, it eventually stopped being effective. “I’ve been living with a particular type of lymphoma for about five years, and I was on chemotherapy, [which is] pretty miserable business, but it was keeping me alive,” Neill told7News.
Also read:Can You Eat Mango If You Have Diabetes?
Facing limited options, Neill enrolled in a clinical trial for CAR T-cell therapy - a revolutionary form of cancer immunotherapy. Unlike chemotherapy, which attacks both healthy and cancerous cells, CAR T-cell therapy reprograms the body’s immune system to specifically target cancer cells. According to experts, the process involves:
According to theCleveland Clinic, CAR T-cell therapy works by modifying a patient’s own T cells, a type of white blood cell, to better recognize and attack cancer. Scientists extract these cells and add a special receptor that helps them identify cancer-specific antigens that the immune system might otherwise miss.
The modified cells are then multiplied in the lab and infused back into the bloodstream. Once inside the body, they actively seek out and destroy cancer cells, while continuing to multiply, providing a long-term immune defense - earning the therapy its name as a “living drug.”
His recovery highlights the growing potential of advanced cancer treatments and the role of clinical trials in saving lives when standard therapies fail.
Despite its promise, CAR T-cell therapy remains expensive and limited in availability. In Australia, it is only accessible through public healthcare for select cancers or privately at a cost exceeding A$600,000 per patient.
Neill is now advocating for broader access to this life-saving treatment, working alongside the Snowdome Foundation to push for policy changes that could make CAR T-cell therapy available to more patients.
CAR T-cell therapy has already shown high success rates in treating blood cancers such as lymphoma and leukemia. While results for solid tumours are still being studied, ongoing research continues to expand its potential. Neill himself emphasized that his recovery is not a miracle, but “science at its best” - a testament to decades of medical research and innovation.
Source: India Latest News, Breaking News Today, Top News Headlines | Times Now
